Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"Essential thrombocythemia"”.
-
Analysis of essential thrombocythemia and its treatment
Essential thrombocythemia (ET) is a rare myeloproliferative neoplasm affecting 43.7 out of every 100,000 people in the United States. The disease is characterized by abnormally high platelet counts, mutational abnormalities in Janus Kinase 2 (JAK2)/Calreticulin (CALR)/myeloproliferative leukemia …
-
EVALUATION OF ASPIRIN RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA PATIENTS
Background. Essential thrombocythemia (ET) is characterized by an increased number of platelets, associated with risk for both bleeding and thrombotic complications. Prophylaxis with 100 mg acetylsalicylic acid (ASA) is indicated in patients at risk. A significant proportion of ET patients (ETs) …
-
ANAGRELIDE E FATTORE DI CRESCITA FIBROBLASTICO-2 (FGF-2) NELLA TROMBOCITEMIA ESSENZIALE
… and fibroblast growth factor-2 levels in essential thrombocythemia, anagrelide and fibroblast growth factor-2 levels in patientswith essential thrombocythemia, abnormal production of interleukin (IL)-6 in essential thrombocythemia, janus kinase V617F mutation and inflammatory interleukins …
-
Quantification Of Cerebral Blood Flow In Mouse Models Of Hematological Disease
… confirmation in animal models of the diseases-essential thrombocythemia and polycythemia vera, specifically. We found cerebral microvessels in the subjects to be largely occluded by leukocytes and platelets, which adhered tightly to the endothelium. In the case of essential thrombocythemia, …
-
Η μελέτη του γονιδίου JAK2 στα μυελοϋπερπλαστικά και άλλα σύνδρομα όσον αφορά το φορτίο νόσου και τη σχέση γονοτύπου/φαινοτύπου
… incidence and response to therapy. Patients with essential thrombocythemia often complain of various subjective neurological symptoms. Among thirty-seven consecutive patients with essential thrombocythemia, 11 presented with neurological symptoms. Brain magnetic resonance imagery failed to detect …
-
Διαταραχές αιμόστασης σε μυελοϋπερπλαστικά νοσήματα
… (PN-MPN) such as polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF), are at a higher risk for venous thrombosis. Thromboelastometry may prove more efficient than conventional hemostatic laboratory tests to evaluate the patient’s thrombotic risk.In this study, …
-
Μελέτη λειτουργικότητας των αιμοπεταλίων στην ιδιοπαθή θρομβοκυτταραιμία
… crucial component of all diagnostic criteria for essential thrombocythemia (ET) has been the exclusion of reactive thrombocytosis (RT). Our aim was to evaluate the diagnostic performance of the PFA-100 collagen-epinephrine (CEPI) cartridge test and epinephrine-induced aggregometry individually, …
-
Μοριακή μελέτη της παθογένειας των χρόνιων μυελοϋπερπλαστικών συνδρόμων
… diseases which include polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). The discovery of recurrent molecular abnormalities such as JAK2V617F and MPL W515L/K has reinforced the original idea of Dameshek in 1951 that these diseases share a common pathogenetic …
-
THE GENETIC REGULATION OF THE RESPONSE OF HEMATOPOIETIC STEM/PROGENITOR CELLS TO THE CYTOSTATIC AGENT HYDROXYUREA
… disorders, such as chronic myelogenous leukemia, essential thrombocythemia, and polycythemia vera. It should come as no surprise then, that common treatments for these diseases often target the proliferative nature of the dysfunctional HSC/HPCs. Thus, the identification of molecular determinants …
-
Understanding the crosstalk between MPN stem and progenitor cells and the bone marrow niche
… cells. These neoplasms, comprised of Essential Thrombocythemia (ET), Polycythaemia Vera (PV) and Primary Myelofibrosis (PMF), often present JAK2V617F mutation and they are accompanied by chronic bone marrow (BM) inflammation, although the source of inflammation is still unclear (Mendez …
-
Φλεγμονή και θρομβωτικά επεισόδια σε ασθενείς με κλασικά μυελοϋπερπλαστικά νοσήματα: Νεότερα δεδομένα και θεραπευτικές δυνατότητες
… vera, PV), την ιδιοπαθή θρομβοκυττάρωση (essential thrombocythemia, ET) και την πρωτοπαθή μυελοίνωση (primary myelofibrosis, PMF). Η κλασική μετάλλαξη JAK2V617F χαρακτηρίζει τη πλειοψηφία των ασθενών με PV, και μικρότερα ποσοστά των ασθενών με ΕΤ και PMF, με δευτερεύουσες τις μεταλλάξεις …
-
Risk factors in the occurrence and diagnosis of myeloid neoplasms
… conferred a small potential increase in risk of essential thrombocythemia (ET), PMF, and other myeloproliferative neoplasms. However, it is difficult to determine whether autoimmune disorders increased the risk of MN, or whether the small elevation in the effect estimate was an artifact of …
-
Ανάλυση της έκφρασης του γονιδίου PRV1 στην αληθή πολυκυτταραιμία και τα θαλασσαιμικά σύνδρομα ως δείκτη ερυθροποίησης: μελέτη της πιθανής εμπλοκής του στους παθογενετικούς μηχανισμούς των ΧΜΥΣ
… Neoplasms MPNs, include Polycythemia Vera (PV), Essential Thrombocythemia (ET), Idiopathic Myelofibrosis (IMF), plus rarer subtypes such us chronic neutrophilic leukaemia (CNL), hypereosinophilic syndrome (HES) and chronic eosinophilic leukaemia (CEL). The identification in 2005 of the V617F …
-
The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms
… classical MPNs, including polycythemia vera, essential thrombocythemia, and myelofibrosis, are diseases of dysregulated JAK2 signaling. In fact, the majority of MPN patients have activating mutations in JAK2 (e.g JAK2-V617F), a tyrosine kinase that contributes to the growth and survival of …
-
Elucidating metabolic alterations in myeloproliferative neoplasms: implications for treatment
… three phenotypes namely Polycythaemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF). The three main somatic mutations leading to MPN are Janus Kinase 2 V617F (JAK2V617F), Janus Kinase 2 exon 12 and Calreticulin (CALR). JAK2V617F was the first driver mutation found in …
-
New molecular and cellular aspects of mutant calreticulin in Myeloproliferative Neoplasms
… Mutations in CALR exon 9 have been identified in essential thrombocythemia and primary myelofibrosis, two myeloproliferative neoplasms (MPNs) characterised by megakaryocyte hyperplasia. Despite the large body of research built around CALR mutations, many aspects of the oncogenic mechanisms of CALR …
-
Ringsingsideroblastische Anämien in Assoziation mit Thrombozytosen : ein heterogenes Krankheitsspektrum
Die Assoziation einer Thrombozytose mit einer RS stellt ein seltenes Krankheitsbild dar, welches sowohl Kennzeichen eines MDS als auch eines MPD besitzt. In der aktuellen WHO-Klassifikation gilt diese sogenannte ET/RS deshalb als nicht eindeutig zu klassifizierende Erkrankung. Untersuchungen an …
-
Die Rolle des Transkriptionsfaktors NF-E2 in der Entstehung der Erythrozytose und Thrombozytose myeloproliferativer Erkrankungen
Die myeloproliferativen Erkrankungen (MPD) Polyzythämia Vera (PV), Essentielle Thrombozythämie (ET) und Primäre Myelofibrose (PMF) sind durch eine deregulierte klonale Expansion reifer Blutzellen gekennzeichnet. Dies führt zu thrombotischen Ereignissen, Minderdurchblutung bei hyperviskosem Blut und …
Page 1 of 2